Skip to main content

Advertisement

SpringerLink
Log in

Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Recently, two genes, peroxisome proliferator activated receptor gamma (PPARγ) and ectonucleotide pyrophosphate phosphodiesterase (ENPP1), have been localized and associated with diabetes and obesity. This report hypothesizes that there is a correlation between the genetic expression of ENPP1 and PPARγ from gastrointestinal tissue and body mass index (BMI).

Methods

Preoperative demographic data were collected from 16 severely morbidly obese patients. Extraneous gastrointestinal tissue was obtained during laparoscopic gastric bypass and gastric banding procedures. The tissue was snap frozen in liquid nitrogen. Initially, RNA extraction was performed on the tissue, followed by reverse transcription using appropriate primers and controls. Subsequently, the samples were subjected to quantitative polymerase chain reaction (PCR). Preoperative demographic data were analyzed for their influence on ENPP1 and PPARγ expression using multivariate analysis and logistic regression models.

Results

Expression of PPARγ and ENPP1 was found in all samples. There was a higher level of PPARγ expression in omental tissue than in enteric tissue. There was no significant difference in the expression of ENPP1 among the different tissue types. The relative level of PPARγ expression in small bowel and gastric tissue was found to be inversely proportional to body mass index (BMI) using linear regression analysis (p = 0.01; r 2 = 0.586). Similarly, PPARγ expression from omental tissue showed an inverse relationship with BMI (p = 0.04; r 2 = 0.576). The levels of ENPP1 expression did not show a correlation with BMI (p = 0.25).

Conclusion

The results suggest that increasing obesity correlates with a decrease in PPARγ expression. This decrease may induce dysfunctional adipocyte differentiation, maturation, and function, leading to diabetes and the metabolic syndrome. Similarly, the increased volume of adipose tissue may lead to a downregulation of PPARγ. The lack of correlation between ENPP1 and BMI may suggest that glucose metabolism is more complex than lipid metabolism. Further evaluation is warranted to establish metabolic pathways for glucose and lipid biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Nadler ST, Attie AD (2001) Please pass the chips: genomic insights into obesity and diabetes. J Nutr 131: 2078–2081

    PubMed  CAS  Google Scholar 

  2. Tontonoz P, Hu E, Graves RA, Budavari AB, Spiegelman BM (1994) mPPARγ2: tissue site-specific regulator of adipocyte enhancer. Genes Dev 8: 1224–1234

    Article  PubMed  CAS  Google Scholar 

  3. Wilson TM, Lambert MH, Kliewer SA (2001) Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 70: 341–367

    Article  Google Scholar 

  4. Chinetti G, Fruchart JC, Staels B (2000) Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497–505

    Article  PubMed  CAS  Google Scholar 

  5. Miyazaki Y, Glass L, Triplitt C, et al. (2001) Effect of rosiglitazone on glucose and nonesterified fatty acid metabolism in type 2 diabetic patients. Diabetologia 44: 2210–2219

    Article  PubMed  CAS  Google Scholar 

  6. Miyazaki Y, Mahankali A, Matsuda M, et al. (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87: 2784–2791

    Article  PubMed  CAS  Google Scholar 

  7. He A, Barak Y, Hevener A, et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not muscle. Proc Natl Acad Sci USA 100: 15712–15717

    Article  PubMed  CAS  Google Scholar 

  8. Hevener AL, He W, Barak Y, et al. (2003) Muscle- specific PPAR-G deletion causes insulin resistance. Nat Med 9: 1491–1497

    Article  PubMed  CAS  Google Scholar 

  9. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-γ, β, and γ in the adult rat. Endocrinology 137: 354–366

    Article  PubMed  CAS  Google Scholar 

  10. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, Ghoussaini M, Wachter C, Hercberg S, Charpentier G, Patsch W, Pattou F, Charles MA, Tounian P, Clement K, Jouret B, Weill J, Maddux BA, Goldfine ID, Walley A, Boutin P, Dina C, Froguel P (2005) Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 37: 863–867

    Article  PubMed  CAS  Google Scholar 

  11. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among U.S. adults, 1999–2000. JAMA 288: 1723–1727

    Article  PubMed  Google Scholar 

  12. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Bio Mol Biol 85: 267–273

    Article  CAS  Google Scholar 

  13. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, et al. (1995) Membrane glycoprotein PC-1 and insulin resistance in non–insulin-dependent diabetes mellitus. Nature 373: 448–451

    Article  PubMed  CAS  Google Scholar 

  14. Maddux BA, Goldfine ID (2000) Membrane glycoprotein PC-1inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 49: 13–19

    Article  PubMed  CAS  Google Scholar 

  15. Weill J, Vanderbecken S, Froguel P (2004) Understanding the rising incidence of type 2 diabetes in adolescence. Arch Dis Child 89: 502–504

    Article  PubMed  CAS  Google Scholar 

  16. Shimomura I, Bashmakov Y, Horton JD (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274: 30028–30032

    Article  PubMed  CAS  Google Scholar 

  17. NIH Conference (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115: 956–961

    Google Scholar 

  18. Pories WJ, MacDonald KG Jr, Flickinger EG, et al. (1992) Is type II diabetes mellitus (NIDDM) a surgical disease. Ann Surg 215: 633–642

    Article  PubMed  CAS  Google Scholar 

  19. Jan JC, Hong D, Pereira N, Patterson EJ (2005) Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results. J Gastrointest Surg 9: 30–41

    Article  PubMed  Google Scholar 

  20. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW (1996) Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93: 10614–10619

    Article  PubMed  CAS  Google Scholar 

  21. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467–470

    Article  PubMed  CAS  Google Scholar 

  22. Ford MD (2001) Clinical toxicology, 1st ed. W.B. Saunders, Philadelphia, PA, pp 427–429

Download references

Author information

Authors and Affiliations

  1. The Department of Surgery, The George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, Suite 6B, Washington, D.C., 20037, USA

    Fred Brody & Scott Celenski

  2. The Department of Biochemistry and Molecular Biology, The George Washington University Medical Center, 2300 Eye St., NW, Ross Hall 520, Washington, D.C., 20037, USA

    Fred Brody, Brian Kluk, Joe Pinzone & Sidney Fu

  3. The George Washington University School of Medicine, Washington, D.C., USA

    Sarah Hill & Ryan Kar

Authors
  1. Fred Brody
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott Celenski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryan Kar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brian Kluk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joe Pinzone
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sidney Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fred Brody.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brody, F., Hill, S., Celenski, S. et al. Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients. Surg Endosc 21, 941–944 (2007). https://doi.org/10.1007/s00464-006-9098-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-006-9098-3

Keywords

Search

Navigation